The possibility of miR-20a/b & miR-93 role in differentiation of naïve CD4+ to Th17 cells in multiple sclerosis
|
R. Naghavian , M.A. Honardoost , A. Hosseini , K. Ghaedi , M. Etemadifar , M. Nasr Esfahani , M. Ganjalikhani Hakemi |
|
|
Abstract: (7508 Views) |
Abstract Background and Objectives Multiple sclerosis (MS) is an autoimmune neurodegenerative disease in which the body’s natural defense system attacks myelin on neuronal cells. One of the most important immune system cells involved in MS is Th17 which is one of the main cells involved in most of autoimmune diseases. Recently, microRNAs (miRNAs) have been remarkably used in treating many kinds of diseases. MicroRNAs are endogenous 22-25 nt RNAs playing an important regulatory roles in cellular and developmental processes. Materials and Methods The goal of this article is to determine miRNAs which possibly have the most effect in the pathway of differentiation to Th17 cells by using miRWalk database and candidate microRNAs that can suppress this pathway and limit the disease’s symptoms. Our in-silico studies identified the possible role of several miRNAs in differentiation of naïve CD4+ cells to Th17 cells. Results miR-93,miR-20a/b are probably applicable to inhibit the differentiation of naïve T cells into Th17 cells to reduce the progress of MS and also to be used as markers of diagnosis of MS in early stages. Conclusions According to our results miR-20a/b&miR-93 can possibly be the key miRNAs, inhibiting the progression of MS by preventing the differentiation to Th17 cells. |
|
Keywords: Key words : Multiple Sclerosis, MicroRNAs, Th17 Cells, Autoimmune Diseases |
|
Full-Text [PDF 315 kb]
(1861 Downloads)
| | Full-Text (HTML) (1462 Views)
|
Type of Study: Research |
Subject:
Imunology Published: 2015/04/7
|
|
|
|